159 related articles for article (PubMed ID: 33344602)
1. Neoadjuvant targeted therapy for apocrine carcinoma of the breast: A case report.
Yang P; Peng SJ; Dong YM; Yang L; Yang ZY; Hu XE; Bao GQ
World J Clin Cases; 2020 Dec; 8(23):6036-6042. PubMed ID: 33344602
[TBL] [Abstract][Full Text] [Related]
2. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
Tsutsumi Y
Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
[TBL] [Abstract][Full Text] [Related]
3. Current and Emerging Therapies for HER2-Positive Women With Metastatic Breast Cancer.
Porter K; Rosenzweig MQ
J Adv Pract Oncol; 2017 Mar; 8(2):164-168. PubMed ID: 29900024
[No Abstract] [Full Text] [Related]
4. A Case Report on Apocrine Encapsulated Papillary Carcinoma of the Breast with Frank Invasion: A Diagnostic Quandary.
Taniguchi K; Yamasaki R; Kajiwara Y; Ichimura K; Yoshino T
Int J Surg Pathol; 2022 Dec; 30(8):939-944. PubMed ID: 35491656
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial.
Hurvitz SA; Martin M; Symmans WF; Jung KH; Huang CS; Thompson AM; Harbeck N; Valero V; Stroyakovskiy D; Wildiers H; Campone M; Boileau JF; Beckmann MW; Afenjar K; Fresco R; Helms HJ; Xu J; Lin YG; Sparano J; Slamon D
Lancet Oncol; 2018 Jan; 19(1):115-126. PubMed ID: 29175149
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of neoadjuvant docetaxel, carboplatin and trastuzumab (TCH) in HER-2-positive breast cancer].
Xu L; Ye JM; Zhu SN; Zhao JY; Xin L; Cheng YJ; Liu Q; Zhang H; Zhang S; Duan XN; Liu YH
Zhonghua Yi Xue Za Zhi; 2018 Mar; 98(12):907-911. PubMed ID: 29665663
[No Abstract] [Full Text] [Related]
7. Triple-negative apocrine carcinoma as a rare cause of a breast lump in a Syrian female: a case report and review of the literature.
Ismail S; Kherbek H; Skef J; Zahlouk N; Abdulal R; Alshehabi Z
BMC Womens Health; 2021 Nov; 21(1):396. PubMed ID: 34823507
[TBL] [Abstract][Full Text] [Related]
8. Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies.
Toomey S; Eustace AJ; Fay J; Sheehan KM; Carr A; Milewska M; Madden SF; Teiserskiene A; Kay EW; O'Donovan N; Gallagher W; Grogan L; Breathnach O; Walshe J; Kelly C; Moulton B; Kennedy MJ; Gullo G; Hill AD; Power C; Duke D; Hambly N; Crown J; Hennessy BT
Breast Cancer Res; 2017 Jul; 19(1):87. PubMed ID: 28750640
[TBL] [Abstract][Full Text] [Related]
9. Apocrine carcinoma of the breast.
Yamazaki M; Nagata Y; Monji S; Shigematsu Y; Baba T; Shimokawa H; Uramoto H; Yamada S; Hanagiri T; Tanaka F
J UOEH; 2011 Dec; 33(4):293-301. PubMed ID: 22259834
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant Chemotherapy with Docetaxel, Carboplatin and Weekly Trastuzumab Is Active in HER2-Positive Early Breast Cancer: Results after a Median Follow-Up of over 4 Years.
Kolberg HC; Akpolat-Basci L; Stephanou M; Aktas B; Hannig CV; Liedtke C
Breast Care (Basel); 2016 Oct; 11(5):323-327. PubMed ID: 27920624
[TBL] [Abstract][Full Text] [Related]
11. Cystic apocrine ductal carcinoma in situ with increased EGFR expression, trisomy 7, and associated focal invasion.
Tajima S; Waki M; Nasu H; Ide Y
Med Mol Morphol; 2016 Sep; 49(3):170-6. PubMed ID: 25374127
[TBL] [Abstract][Full Text] [Related]
12. A rare case of isolated adrenal metastasis of invasive ductal breast carcinoma.
Andjelić-Dekić N; Božović-Spasojević I; Milošević S; Matijašević M; Karadžić K
Srp Arh Celok Lek; 2014; 142(9-10):597-601. PubMed ID: 25518541
[TBL] [Abstract][Full Text] [Related]
13. Application of neoadjuvant chemotherapy combined with anlotinib in occult breast cancer: A case report and review of literature.
Zhang Y; Wu D; Zhao B; Tian XL; Yao TC; Li F; Liu WF; Shi AP
World J Clin Cases; 2021 Feb; 9(4):919-926. PubMed ID: 33585640
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.
Gatalica Z
Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507
[TBL] [Abstract][Full Text] [Related]
15. [Phase II clinical trial of neoadjuvant therapy with carboplatin plus paclitaxel for locally advanced triple-negative breast cancer].
Ma WY; Zhang P; Zhang BL; Wang X; Xu XZ; Zheng S; Wang JY; Cai RG; Yuan P; Ma F; Fan Y; Xu BH
Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):770-4. PubMed ID: 23291072
[TBL] [Abstract][Full Text] [Related]
16. Retrospective study of the efficacy and safety of neoadjuvant docetaxel, carboplatin, trastuzumab/pertuzumab (TCH-P) in nonmetastatic HER2-positive breast cancer.
Tiwari SR; Mishra P; Raska P; Calhoun B; Abraham J; Moore H; Budd GT; Fanning A; Valente S; Stewart R; Grobmyer SR; Montero AJ
Breast Cancer Res Treat; 2016 Jul; 158(1):189-193. PubMed ID: 27324504
[TBL] [Abstract][Full Text] [Related]
17. [A case of breast cancer treated with neoadjuvant chemotherapy and segmentectomy].
Iizuka M; Enomoto K; Sakurai K
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2027-9. PubMed ID: 23267965
[TBL] [Abstract][Full Text] [Related]
18. Apocrine adenocarcinoma of the breast: A rare special subtype with divergent theranostic markers.
Sujata S; Sudeep K; Taruna Y; Mahendra L
J Cancer Res Ther; 2023; 19(2):477-479. PubMed ID: 37313919
[TBL] [Abstract][Full Text] [Related]
19. Breast Apocrine Carcinoma Detected Incidentally as Axillary Lymphadenopathy in a CT Scan.
Barron M; Asaad A; Idaewor P; Rasheed N; Saad Abdalla Al-Zawi A
Cureus; 2021 Oct; 13(10):e18523. PubMed ID: 34754678
[TBL] [Abstract][Full Text] [Related]
20. Squamous cell carcinoma with apocrine features of the breast: A case report.
Naito Y; Yamaguchi R; Tanaka M; Saruwatari A; Torii Y; Tsukamoto T; Nishida N; Higaki K
Oncol Lett; 2014 Mar; 7(3):647-650. PubMed ID: 24520287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
